
CAS 42839-35-0
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
1 produits concernés.
Azocan-3-amine
CAS :<p>Azocan-3-amine is a third-generation, small molecule inhibitor of the ErbB family of receptor tyrosine kinases. It was discovered by a team of scientists at AstraZeneca and has been evaluated in clinical trials for the treatment of various cancers. Azocan-3-amine inhibits the activity of EGFR and its two most common mutations, T790M and C797S. This drug is currently in Phase I/II trials for EGFR T790M mutation positive non-small cell lung cancer (NSCLC) and metastatic breast cancer patients with EGFR c797s mutation.</p>Formule :C7H16N2Degré de pureté :Min. 95%Masse moléculaire :128.22 g/mol
